Medical Oncologist
Treatment options
Who should genuinely consider risk-reducing mastectomy?
Risk-reducing mastectomy is worth discussing for people with a much higher than average chance of breast cancer, such as BRCA carriers. For most other women the benefit is small. This page explains which groups may consider it, when screening is usually advised instead, and why genetic counselling comes first.
MM
Medically reviewed by Dr. Muralidhar MuddusettyConsultant Surgical Oncologist · MBBS (AIIMS), MS (Surgery, AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Who should genuinely consider a risk-reducing mastectomy?
- Groups where the discussion is worthwhile
- Situations where surgery is generally not recommended
- The vocabulary, in plain language
- Honest realities about who benefits
- Why genetic counselling comes first
- Personal factors that shape the decision
- What people assume about who needs preventive surgery
- Common questions about who should consider preventive mastectomy
The short answer
Who should genuinely consider a risk-reducing mastectomy?
Risk-reducing mastectomy is worth serious discussion for a fairly small group of people whose chance of breast cancer is well above average. The clearest group is women who carry a harmful change in a high-risk gene, mainly BRCA1 or BRCA2, and also PALB2, TP53 and a few others. It may also be discussed for women with a very strong family history of breast or ovarian cancer, even when no gene change is found, if a genetics team estimates a high lifetime risk. Another group is people who had radiotherapy to the chest at a young age, often for Hodgkin lymphoma. Women who already have cancer in one breast and carry a high-risk gene may also consider removing the other breast. For most other women, including those with one relative who had breast cancer later in life, dense breasts, benign lumps, or an average-risk cancer in one breast, the benefit of preventive surgery is usually small and does not outweigh the risks, so screening and regular follow-up are generally advised instead. Anxiety about cancer is very real and deserves support, but on its own it is rarely a reason for surgery. Considering the operation does not mean you must have it. Many high-risk women choose careful screening, and a good team will respect either path after a full discussion.
High inherited risk is the main reason
Harmful changes in genes such as BRCA1 and BRCA2 are the most common reason for the discussion.
Average risk rarely justifies it
For most women, the downsides of surgery outweigh the small gain.
Considering is not deciding
Screening remains a valid choice even for high-risk women.
This page gives general information only. A genetics and breast team can assess your own risk.Who it may suit
Groups where the discussion is worthwhile
These groups have a high enough risk that the option deserves a careful conversation.
BRCA1 and BRCA2 carriers
Women with these gene changes have a high lifetime chance of breast cancer, often at a younger age.
Other high-risk genes
Changes in genes such as PALB2 and TP53 can also carry substantial risk.
Moderate-risk genes are usually managed with screening.Very strong family history
Several close relatives with breast or ovarian cancer, especially young, with a high estimated lifetime risk.
Chest radiotherapy when young
People treated with chest radiotherapy in childhood or early adulthood.
Often discussed with
- Early yearly MRI screening
- Specialist follow-up clinics
- Heart and thyroid checks
Usually not advised
Situations where surgery is generally not recommended
Situation
What is usually suggested instead
One relative with breast cancer in later life
Risk assessment and screening suited to your family history
Dense breasts
Discussion of screening methods, sometimes with ultrasound
Benign lumps or cysts
Appropriate checks, since most benign conditions add little risk
Cancer in one breast without high-risk genes
Treating the cancer well and regular screening of the other breast
Worry without raised risk
Counselling, reassurance and routine screening
Not sure whether this applies to you?
Ask an oncologistWords you may hear
The vocabulary, in plain language
- High-risk gene
- A gene whose harmful changes greatly raise the chance of breast cancer, such as BRCA1 or BRCA2.
- Moderate-risk gene
- A gene whose changes raise risk less, such as CHEK2 or ATM, usually managed with screening.
- Variant of uncertain significance
- A gene change whose effect on cancer risk is not yet known, and not a reason for surgery on its own.
- Cascade testing
- Offering genetic testing to relatives once a gene change is found in the family.
- Risk assessment
- An estimate of your breast cancer risk using family history, genes and personal factors.
- Lobular carcinoma in situ
- A non-invasive change that raises breast cancer risk, usually managed with screening.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Being straight with you
Honest realities about who benefits
Deciding whether surgery is right for you is rarely simple, even in high-risk groups.
Genetic results can be unclear
An uncertain gene result should not lead to surgery until its meaning is understood.
Family history alone can mislead
Large families with many women give more information than small families, so risk estimates vary in accuracy.
Fear is real but not a measure of risk
Strong anxiety deserves support, but it does not by itself mean your risk is high.
Every surgery has lasting effects
Loss of breast feeling, breastfeeding and possible further operations are permanent considerations.
What this page cannot tell you
It cannot place you in a risk group. Genetic counselling and a specialist assessment can.
First step
Why genetic counselling comes first
For most people wondering about preventive surgery, genetic counselling is the right starting point.
It clarifies who should be tested
Often the most useful test is on a relative who has had cancer, because a result there guides the family.
It explains what a result means
A positive, negative or uncertain result each carries different implications for surgery and screening.
It estimates risk when no gene is found
Specialists can use family history models to judge whether your risk is still high.
It covers the wider family
Brothers, sons and daughters may also benefit from knowing, including for prostate and other cancers.
It gives time to think
Counselling sessions allow space to process results before making big decisions.
Beyond risk
Personal factors that shape the decision
Two women with the same risk may make different, equally sensible choices. These factors often weigh in.
Your age
Younger women have more years of risk ahead, while older women may gain less.
Family and breastfeeding plans
Some women wait until they have had children and breastfed before considering surgery.
Experience of screening
Frequent callbacks, biopsies or anxiety before scans lead some women towards surgery.
Feelings about your body
How you feel about losing your breasts, and about reconstruction, is central to the choice.
Commonly believed
What people assume about who needs preventive surgery
Any family history of breast cancer means I should consider surgery.
Most family histories carry only a modest rise in risk, managed with screening.
A gene result of uncertain meaning is a reason for surgery.
Uncertain results are usually managed based on family history, not the variant.
Every BRCA carrier must have surgery.
Surgery is one option; many carriers choose screening.
Dense breasts are a reason to remove them.
Dense breasts raise risk slightly and are managed with suitable screening.
Questions we are asked
Common questions about who should consider preventive mastectomy
My mother had breast cancer. Should I consider surgery?
Not necessarily. One close relative with breast cancer raises risk somewhat, but for most women not enough to justify surgery. The age your mother was diagnosed, other affected relatives and whether a gene change is found all matter. A genetics assessment can clarify this.
What if I test negative but my family has many cancers?
A negative result is most meaningful when a specific gene change is already known in the family. If no family gene change has been found, your risk may still be raised because of genes not yet identified. Specialists can estimate your risk using family history and advise on screening or surgery.
Should women with CHEK2 or ATM changes have surgery?
These moderate-risk genes raise breast cancer risk less than BRCA1 or BRCA2. Most guidelines suggest enhanced screening rather than preventive surgery, unless family history adds significant extra risk. Discuss your full picture with a genetics team.
I have cancer in one breast. Should I remove the other?
For women without a high-risk gene change, the chance of cancer in the other breast is usually low, and removing it generally does not improve survival. For BRCA carriers or those with very strong family history, it may be worth discussing. Genetic testing can help guide this choice.
Is severe anxiety a valid reason for surgery?
Anxiety about cancer deserves proper attention and support. Counselling and a clear explanation of your real risk often ease worry. For women at high risk, reducing anxiety can be part of the reason for surgery, but for average-risk women the downsides usually outweigh the benefit.
Can men consider preventive mastectomy?
Men with BRCA2 changes have a raised risk of breast cancer, but it is still much lower than in women. Preventive mastectomy is rarely advised for men. Instead, they are usually encouraged to be aware of chest changes and to discuss screening for other cancers, such as prostate cancer.
Does a benign breast lump raise my risk enough?
Most benign lumps, such as fibroadenomas and cysts, add little or no extra risk. A few benign changes, such as atypical hyperplasia, raise risk more, but they are usually managed with screening and sometimes risk-reducing medicines rather than surgery.
How do I start this conversation with a doctor?
Write down your family history, including who had cancer, what type and at what age. Ask your doctor for a referral for genetic counselling or to a high-risk breast clinic. Bring any earlier genetic test reports, and ask for time to think after each discussion.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- National Cancer Institute — Surgery to reduce the risk of breast cancer
- NHS — Breast cancer in women: causes and inherited genes
- Cancer Research UK — Inherited genes and cancer types
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.